Ubiquitin C-terminal hydrolase-L1 is a key regulator of tumor cell invasion and metastasis

Oncogene

Volumn 28, Issue 1, 2009, Pages 117-127

  Kim, H J ^a,a   Kim, Y M ^a   Lim, S ^a   Nam, Y K ^a   Jeong, J ^a   Lee, K J ^a  

^a Ewha Womans University   (South Korea)

Author keywords

Akt activation; Deubiquitinating enzyme; Lung cancer; Metastasis; Proteomics; Tumor invasion; UCH L1

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; UBIQUITIN THIOLESTERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; CELL ADHESION; CELL INVASION; CELL STRUCTURE; EXPERIMENTAL MOUSE; IN VITRO STUDY; IN VIVO STUDY; LUNG NON SMALL CELL CANCER; METASTASIS; MIGRATION; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL; RNA INTERFERENCE; TUMOR CELL;

ANIMALS; CELL CYCLE; CELL MOVEMENT; ENZYME ACTIVATION; GENE SILENCING; HUMANS; LUNG NEOPLASMS; MAP KINASE KINASE 4; MELANOMA; MICE; MICE, INBRED BALB C; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-AKT; UBIQUITIN THIOLESTERASE;

EID: 58149350275     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2008.364     Document Type: Article

References (24)

1. Bittencourt Rosas SL, Caballero OL, Dong SM, da Costa Carvalho Mda G, Sidransky D, Jen J. (2001). Methylation status in the promoter region of the human PGP9.5 gene in cancer and normal tissues. Cancer Lett 170: 73-79.
2. Brichory F, Beer D, Le Naour F, Giordano T, Hanash S. (2001). Proteomics-based identification of protein gene product 9.5 as a tumor antigen that induces a humoral immune response in lung cancer. Cancer Res 61: 7908-7912.
3. Caballero OL, Resto V, Patturajan M, Meerzaman D, Guo MZ, Engles J et al. (2002). Interaction and colocalization of PGP9.5 with JAB1 and p27(Kip1). Oncogene 21: 3003-3010.
4. Diebold BA, Fowler B, Lu J, Dinauer MC, Bokoch GM. (2004). Antagonistic cross-talk between Rac and Cdc42 GTPases regulates generation of reactive oxygen species. J Biol Chem 279: 28136-28142.
5. Gong B, Cao Z, Zheng P, Vitolo OV, Liu S, Staniszewski A et al. (2006). Ubiquitin hydrolase UCH-L1 rescues b-amyloid-induced decreases in synaptic function and contextual memory. Cell 126: 775-788.
6. Hibi K, Westra WH, Borges M, Goodman S, Sidransky D, Jen J. (1999). PGP9.5 as a candidate tumor marker for non-small-cell lung cancer. Am J Pathol 155: 711-715.
7. Honda K, Yamada T, Endo R, Ino Y, Gotoh M, Tsuda H et al. (1998). Actinin-4, a novel actin-bundling protein associated with cell motility and cancer invasion. J Cell Biol 140: 1383-1393.
8. Huang C, Jacobson K, Schaller MD. (2004). A role for JNK-paxillin signaling in cell migration. Cell Cycle 3: 4-6.
9. Kim YM, Seo J, Kim YH, Jeong J, Joo HJ, Lee DH et al. (2007). Systemic analysis of tyrosine phosphorylated proteins in angiopoietin-1 induced signaling pathway of endothelial cells. J Proteome Res 6: 3278-3290.
10. Kurisu S, Suetsugu S, Yamazaki D, Yamaguchi H, Takenawa T. (2005). Rac-WAVE2 signaling is involved in the invasive and metastatic phenotypes of murine melanoma cells. Oncogene 24: 1309-1319.
11. Liu Y, Fallon L, Lashuel HA, Liu Z, Lansbury Jr PT. (2002). The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility. Cell 111: 209-218.
12. Liu Y, Lashuel HA, Choi S, Xing X, Case A, Ni J et al. (2003). Discovery of inhibitors that elucidate the role of UCH-L1 activity in the H1299 lung cancer cell line. Chem Biol 10: 837-846.
13. Lowe J, McDermott H, Landon M, Mayer RJ, Wilkinson KD. (1990). Ubiquitin carboxyl-terminal hydrolase (PGP 9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases. J Pathol 161: 153-160.
14. Osaka H, Wang YL, Takada K, Takizawa S, Setsuie R, Li H et al. (2003). Ubiquitin carboxy-terminal hydrolase L1 binds to and stabilizes monoubiquitin in neuron. Hum Mol Genet 12: 1945-1958.
15. Polyak K, Lee MH, Erdjument-Bromage H, Koff A, Roberts JM, Tempst P et al. (1994). Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78: 59-66.
16. Reddy KB, Nabha SM, Atanaskova N. (2003). Role of MAP kinase in tumor progression and invasion. Cancer Metastasis Rev 22: 395-403.
17. Saigoh K, Wang YL, Suh JG, Yamanishi T, Sakai Y, Kiyosawa H et al. (1999). Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice. Nat Genet 23: 47-51.
18. Song EJ, Yim SH, Kim E, Kim NS, Lee KJ. (2005). Human Fas-associated factor 1, interacting with ubiquitinated proteins and valosin-containing protein, is involved in the ubiquitin-proteasome pathway. Mol Cell Biol 25: 2511-2524.
19. Tezel E, Hibi K, Nagasaka T, Nakao A. (2000). PGP9.5 as a prognostic factor in pancreatic cancer. Clin Cancer Res 6: 4764-4767.
20. Toyoshima H, Hunter T. (1994). p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78: 67-74.
21. Wojciak-Stothard B, Tsang LY, Haworth SG. (2005). Rac and Rho play opposing roles in the regulation of hypoxia/reoxygenation-induced permeability changes in pulmonary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol 288: L749-L760.
22. Yamana N, Arakawa Y, Nishino T, Kurokawa K, Tanji M, Itoh RE et al. (2006). The Rho-mDia1 pathway regulates cell polarity and focal adhesion turnover in migrating cells through mobilizing Apc and c-Src. Mol Cell Biol 26: 6844-6858.
23. Yamazaki T, Hibi K, Takase T, Tezel E, Nakayama H, Kasai Y et al. (2002). PGP9.5 as a marker for invasive colorectal cancer. Clin Cancer Res 8: 192-195.
24. Yoeli-Lerner M, Toker A. (2006). Akt/PKB signaling in cancer: a function in cell motility and invasion. Cell Cycle 5: 603-605.